In 2011, sales of calming and sleeping
products increased by 5%, to reach a value of £47 million. This category
is dominated by a few leading market players and private label. The use
of herbal and natural remedies to aid sleep is increasing, and has led
to most branded manufacturers adding herbal variants to their product
listings.
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years'' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Euromonitor International''s Calming and Sleeping in
United Kingdom report offers a comprehensive guide to the size and shape
of the market at a national level. It provides the latest retail sales
data 2007-2011, allowing you to identify the sectors driving growth.
Forecasts to 2016 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Calming and Sleeping market;* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years'' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Calming and Sleeping in the United Kingdom
Published: June 2012 No. of Pages: 31 Price: US $ 900
Table of Contents
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Calming and Sleeping: Value 2006-2011
Table 2 Sales of Calming and Sleeping: % Value Growth 2006-2011
Table 3 Calming and Sleeping Company Shares by Value 2007-2011
Table 4 Calming and Sleeping Brand Shares by Value 2008-2011
Table 5 Forecast Sales of Calming and Sleeping: Value 2011-2016
Table 6 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016
Boots UK Ltd in Consumer Health (united Kingdom)
Strategic Direction
Key Facts
Summary 1 Boots UK Ltd: Key Facts
Summary 2 Boots UK Ltd: Operational Indicators
Company Background
Production
Summary 3 BCM: Production Statistics 2011
Competitive Positioning
Summary 4 Boots UK Ltd: Competitive Position 2011
GlaxoSmithKline Plc in Consumer Health (united Kingdom)
Strategic Direction
Key Facts
Summary 5 GlaxoSmithKline Plc: Key Facts
Company Background
Production
Competitive Positioning
Summary 6 GlaxoSmithKline Plc: Competitive Position 2011
Executive Summary
Growth Despite Tough Trading Conditions and Policy Uncertainty
Sports Nutrition Hits the Mainstream While Other Categories Return To the Margins
Innovation the Key for Brands To Compete With Private Label
Supermarkets and Internet Retailing Gain Share But Specialists Fight Back
Growth Picks Up Marginally Over the Forecast Period
Key Trends and Developments
Opportunities for Growth in A Dire Economic Climate
Current Impact
Outlook
Future Impact
Innovation Key for Differentiation and Market Capture
the Days of Stellar Switches Are Over (for Now)
Uncertain Outlook for Traditional Herbal Products
Promoting Responsible Self-medication: Where Profit Meets Policy
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 8 Life Expectancy at Birth 2006-2011
Market Data
Table 9 Sales of Consumer Health by Category: Value 2006-2011
Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 11 Consumer Health Company Shares 2007-2011
Table 12 Consumer Health Brand Shares 2008-2011
Table 13 Penetration of Private Label by Category 2006-2011
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
EU Legislation
UK Environment
Self-medication/self-care and Preventative Medicine
Switches
Summary 7 OTC Switches 2009-2011
Sources
Summary 8 Research Sources
Published: June 2012 No. of Pages: 31 Price: US $ 900
Table of Contents
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Calming and Sleeping: Value 2006-2011
Table 2 Sales of Calming and Sleeping: % Value Growth 2006-2011
Table 3 Calming and Sleeping Company Shares by Value 2007-2011
Table 4 Calming and Sleeping Brand Shares by Value 2008-2011
Table 5 Forecast Sales of Calming and Sleeping: Value 2011-2016
Table 6 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016
Boots UK Ltd in Consumer Health (united Kingdom)
Strategic Direction
Key Facts
Summary 1 Boots UK Ltd: Key Facts
Summary 2 Boots UK Ltd: Operational Indicators
Company Background
Production
Summary 3 BCM: Production Statistics 2011
Competitive Positioning
Summary 4 Boots UK Ltd: Competitive Position 2011
GlaxoSmithKline Plc in Consumer Health (united Kingdom)
Strategic Direction
Key Facts
Summary 5 GlaxoSmithKline Plc: Key Facts
Company Background
Production
Competitive Positioning
Summary 6 GlaxoSmithKline Plc: Competitive Position 2011
Executive Summary
Growth Despite Tough Trading Conditions and Policy Uncertainty
Sports Nutrition Hits the Mainstream While Other Categories Return To the Margins
Innovation the Key for Brands To Compete With Private Label
Supermarkets and Internet Retailing Gain Share But Specialists Fight Back
Growth Picks Up Marginally Over the Forecast Period
Key Trends and Developments
Opportunities for Growth in A Dire Economic Climate
Current Impact
Outlook
Future Impact
Innovation Key for Differentiation and Market Capture
the Days of Stellar Switches Are Over (for Now)
Uncertain Outlook for Traditional Herbal Products
Promoting Responsible Self-medication: Where Profit Meets Policy
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 8 Life Expectancy at Birth 2006-2011
Market Data
Table 9 Sales of Consumer Health by Category: Value 2006-2011
Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 11 Consumer Health Company Shares 2007-2011
Table 12 Consumer Health Brand Shares 2008-2011
Table 13 Penetration of Private Label by Category 2006-2011
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
EU Legislation
UK Environment
Self-medication/self-care and Preventative Medicine
Switches
Summary 7 OTC Switches 2009-2011
Sources
Summary 8 Research Sources
No comments:
Post a Comment